First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Response

(MedPage Today) -- WASHINGTON -- The gene therapy nadofaragene firadenovec (Adstiladrin) continued to demonstrate clinical activity in patients with high-risk bladder cancer, researchers reported. The long-term follow-up data came from a phase...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news